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Abstract Ficolins are characterised by the presence of collagen-
like and fibrinogen-like (FBG) sequences. Human L-ficolin is
synthesised in the liver and secreted into blood circulation. In
previous studies, it was shown to bind to N-acetyl-D-glucosamine
(GlcNAc). In the present study, its detailed sugar specificity and
binding site have been investigated. It was found to bind to
GlcNAc and GalNAc (N-acetyl-D-galactosamine) while showing
no significant affinity for the precursor sugars. The structure in
these molecules which is recognised by L-ficolin has been deduced
to include an amide (-CO-NH-) or similar group. L-Ficolin was
digested with collagenase and the collagenase resistant FBG
domain was shown to bind to GlcNAc. Its levels in adult and cord
blood-derived human plasma were also determined and showed
that adult plasma contains approximately three times more
L-ficolin than that of newborn babies.
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1. Introduction
Ficolins, the collectins and C1q comprise a family of pro-
teins that contain collagen-like sequences and have similar
domain organisations [1]. As a result, all these proteins are
assembled into a ‘bundle-of-tulips’ or ‘cruciform’ overall
structure [1,2]. L-Ficolin is approximately 400 kDa and elec-
tron microscopy reveals that it is probably composed of 12
polypeptide chains assembled into four trimeric ‘structural
units’ that are disulphide-linked via the N-terminal region
[2]. The tetrameric L-¢colin molecules can also form non-co-
valent, ‘spindle-like’ dimers [2]. However, the three types of
proteins have distinct independently folded C-terminal glob-
ular domains [1,2] which form the basis for assigning the three
types of proteins to distinct protein families [1,3,4]. C1q has
C-terminal sequences which are related to globular sequences
in certain collagens and bind to immune complexes leading to
complement activation [3,5]. The collectins have C-terminal
Ca2-dependent carbohydrate recognition domains (C-type
CRDs) which bind to sugar residues on the surface of micro-
organisms leading to killing of bound microbes through com-
plement activation and/or enhanced phagocytosis [1,6^8]. The
corresponding regions in the ¢colin polypeptides are related to
the C-terminal halves of ¢brinogen L and Q chains [1,9^11].
Similar sequences have also been found in a number of other
proteins and have been termed the ¢brinogen-like or FBG
domains [12].
Although the FBG domain is unrelated to CRD [1,9^
11,13], L-¢colin has been shown, like the collectins, to bind
to sugar structures [2,11,14]. However, unlike the collectins,
human L-¢colin could bind to GlcNAc in the absence of Ca2
[2,14]. L-Ficolin has also been identi¢ed as an elastin- and
corticosteroid-binding protein [15,16]. Together with the ini-
tial isolation of porcine ¢colin as a transforming growth fac-
tor-L1-binding protein [9], ¢colins apparently have a⁄nity for
various unrelated structures. It has also been shown recently
that L-¢colin simply bound to CNBr-activated and Tris-re-
acted Sepharose at its GlcNAc-binding site(s) [14]. The bind-
ing of L-¢colin to GlcNAc on Salmonella typhimurium has
been shown to enhance the phagocytosis of bound bacteria
by polymorphonuclear leucocytes [11].
In the present study, the sugar speci¢city of L-¢colin has
been further investigated. The structures in the sugars which
are recognised by L-¢colin have also been suggested and the
sugar binding site in L-¢colin has been assigned to the FBG
domain. The level of L-¢colin in adult and cord blood-derived
human plasma was also determined.
2. Materials and methods
CNBr-activated Sepharose, glutaraldehyde, biotinamidocaproate N-
hydroxysuccinimide ester, streptavidin-alkaline phosphatase, galac-
tose, galactosamine, GalNAc, glucose, glucosamine and GlcNAc
were purchased from Sigma Chemical Co. (St. Louis, MO, USA).
GlcNAc-Sepharose was prepared following the method described by
Fornstedt and Porath [17]. Expired human plasma and fresh human
plasma samples were obtained from apparently healthy adult blood
donors and cord blood samples were collected in the National Uni-
versity Hospital, Singapore.
2.1. Puri¢cation of L-¢colin
Human L-¢colin was puri¢ed from plasma essentially as previously
reported [14] with slight modi¢cations. Human plasma was, after re-
moval of debris by centrifugation, passed through a Sepharose 4B
column (50 ml packed volume), which had been equilibrated with a
TBS-TEDTA bu¡er (50 mM Tris, 150 mM NaCl, 0.05% (v/v) Tween
20 and 2 mM EDTA, pH 7.8), and then applied onto a GlcNAc-
Sepharose column (50 ml) similarly equilibrated. After washing, the
column was eluted with 200 mM GlcNAc in TBS-TEDTA. The eluate
was diluted with 2 volumes of bu¡er D (50 mM Tris, 0.05% (v/v)
Tween 20 and 2 mM EDTA, pH 7.8) and then subjected to FPLC
ion-exchange on a mono-Q column. The FPLC step was repeated
with the £ow-through from the mono-Q column until L-¢colin was
not detectable in the subsequent eluate of a NaCl gradient. Fractions
containing L-¢colin were pooled and applied onto a CNBr-activated
and Tris-reacted Sepharose column (5 ml). After washing with TBS-
TEDTA, L-¢colin was eluted from the column with 200 mM GlcNAc
in TBS-TEDTA.
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2.2. Assay for sugar speci¢cities of puri¢ed L-¢colin
Puri¢ed human L-¢colin (30 Wg) was re-bound to CNBr-activated
and Tris-reacted Sepharose columns (1 ml). The columns were eluted
sequentially either with (100 mM) glucose, glucosamine and GlcNAc,
or with the same concentration of galactose, galactosamine and Gal-
NAc. The re-bound L-¢colin was also eluted sequentially with 10 mM
glutathione, 50 mM glutathione and 100 mM GlcNAc. Fractions of
each elution were examined by SDS-PAGE, under reducing condi-
tions, on 10% (w/v) gels.
2.3. Collagenase digestion and identi¢cation of GlcNAc-binding site
in L-¢colin
Puri¢ed L-¢colin (20 Wg) was subjected to collagenase digestion as
described previously [14]. The digest was applied onto a GlcNAc-
Sepharose column (2 ml) and, after washing of the column with
TBS-TEDTA (10 ml), the column was eluted with 200 mM GlcNAc
in TBS-TEDTA collecting 1 ml fractions. The digest, the £ow-through
from the GlcNAc-Sepharose column, the washing, and the GlcNAc
eluate were subjected to SDS-PAGE under reducing conditions on a
10% (w/v) gel.
2.4. Assay for plasma levels of human L-¢colin(s)
Puri¢ed L-¢colin was used to immunise New Zealand White rabbits
and IgG was isolated from the antiserum by sodium sulphate precip-
itation. A fraction of the puri¢ed IgG (5 mg) was labeled with biotin
following the method described by Guesdon et al. [18].
The level of L-¢colin in plasma samples was measured by a sand-
wich antigen capture assay. Brie£y, microtitre plates were coated with
rabbit anti-L-¢colin IgG at 1 Wg/well. After washing with TBS-TED-
TA-BSA (BSA 1 mg/ml) and blocking with the same bu¡er for 1 h at
room temperature, the plates were incubated with plasma samples
diluted in TBS-TEDTA. The plates were washed with PBS and then
incubated for 15 min with 0.125% (v/v) glutaraldehyde dissolved in
PBS. Free binding sites were blocked for 1 h with 0.5 M ethanol-
amine. After washing with TBS-TEDTA-BSA, the plates were incu-
bated for 2 h with biotinylated anti-L-¢colin IgG (0.1 Wg/well) and,
after washing, incubated for 2 h with streptavidin-alkaline phospha-
tase diluted 3000-fold in TBS-TEDTA-BSA. The plates were washed
and developed by incubation with a p-nitrophenyl phosphate disodi-
um solution (1 mg/ml). The L-¢colin concentration in each plasma
sample was determined by comparison with the standard curve of a
plasma pool which was assayed in the same plates and whose L-¢colin
concentration had been determined using puri¢ed L-¢colin as a refer-
ence.
3. Results
3.1. Sugar speci¢city of L-¢colin
L-Ficolin has previously been shown to bind to a number of
unrelated structures including elastin, corticosteroid and
GlcNAc. Unlike the collectins, it binds to GlcNAc in the
absence of Ca2 [2,14]. L-Ficolin has also been shown to
bind to CNBr-activated Sepharose from which it could be
eluted with GlcNAc [14]. In the present study, the sugar spe-
ci¢city of L-¢colin has been further investigated. Puri¢ed L-
¢colin was re-bound to CNBr-activated and Tris-reacted Se-
pharose and was then sequentially eluted with two sets of
sugars. The bound L-¢colin was not eluted from the column
with glucose and glucosamine, but was eluted with GlcNAc
(Fig. 1a). Similarly, galactose, galactosamine and GalNAc
were used sequentially to elute bound L-¢colin. However, L-
¢colin was only eluted with GalNAc (Fig. 1b). Both GlcNAc
and GalNAc are di¡erent from their amino sugar precursors
by modi¢cation of the amino group into an acetamide (CH3-
CO-NH-) group (Fig. 2). Interestingly, L-¢colin was also
eluted with glutathione, which has no structural similarity to
GlcNAc and GalNAc apart from the presence of two similar
amide groups (Fig. 2). L-Ficolin binds to CNBr-activated and
Tris-reacted Sepharose but not to underivatised Sepharose
[14]. It is interesting that a similar structure (-CNH-NH-) is
also generated in CNBr-activated Sepharose when the resin is
reacted with Tris (Fig. 2). Therefore, the amide group in these
molecules/structures is likely to be, at least part of, the L-
¢colin-binding site(s).
3.2. Sugar binding site in L-¢colin
L-Ficolin was digested with collagenase in order to isolate
the FBG domain. The digestion yielded a collagenase-resistant
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Fig. 1. Sugar speci¢city of L-¢colin. L-Ficolin was applied to a
CNBr-activated and Tris-reacted Sepharose column (1 ml). After
washing with TBS-TEDTA, the column was eluted sequentially
with (a) 100 mM D-glucose (lanes 1^3), D-glucosamine (lanes 4^6),
and then GlcNAc (lanes 7^9), (b) 100 mM D-galactose (lanes 1^3),
D-galactosamine (lanes 4^6), and then GalNAc (lanes 7^9), or (c)
10 mM glutathione (lanes 1^3), 50 mM glutathione (lanes 4^6), and
then 100 mM GlcNAc (lanes 7^9). Molecular weight standards
are included between each elution and are 58 kDa, 40 kDa, and
32 kDa, respectively, from the top.
Fig. 2. Molecular structures of GlcNAc, GalNAc, glutathione and
CNBr-activated/Tris-derivatised Sepharose. Chemical reactions
which generate these structures from their precursors are also illus-
trated. The amide groups (-CO-NH-) in GlcNAc, GalNAc and glu-
tathione and a similar group (-CNH-NH-) in Tris-derivatised Se-
pharose, potentially involved in L-¢colin binding, are shaded.
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fragment of approximately 32 kDa under reducing conditions
(Fig. 3, lanes a and b). The reduction of 8 kDa when com-
pared with the undigested 40 kDa L-¢colin polypeptide is
consistent with the loss of the N-terminal segment and the
collagen-like sequence (total of 71 residues) after collagenase
digestion [11]. Therefore, the 32 kDa fragment is most likely
to correspond to the FBG domain. Despite the presence of
two additional cysteine residues in the N-terminal region of
the L-¢colin FBG domain, corresponding to the neck regions
of the collectins [7,10,11], no covalent FBG trimer (predicted
molecular weight of approximately 90 kDa) was detected after
collagenase digestion of L-¢colin, as judged by SDS-PAGE
under non-reducing conditions and by Western blotting
(data not shown). By a⁄nity chromatography analysis of
the collagenase digest, it was shown that the 32 kDa fragment
could re-bind to GlcNAc-Sepharose as it was not detected in
the £ow-through (data not shown). The bound 32 kDa frag-
ment was subsequently, after washing of the column with
5 volumes of TBS-TEDTA, eluted from the column with
GlcNAc in the second and third fractions (Fig. 3, lanes d
and e). Therefore, like the collectins, L-¢colin probably also
binds to sugars via its C-terminal globular FBG domains.
3.3. Plasma levels of L-¢colin
Eighty adult human plasma and 24 cord blood plasma
samples were assayed for levels of L-¢colin (Fig. 4). The con-
centration of L-¢colin in a pooled plasma sample was deter-
mined using puri¢ed L-¢colin of known concentration as a
reference. The level of L-¢colin in the 80 adult human plasma
samples showed signi¢cant variation ranging from 1 to 7 Wg/
ml with an average of 4.13 Wg/ml. However, most samples
(s 90%) contained L-¢colin at concentrations of 2.5^5.5 Wg/
ml. Cord blood plasma samples were similarly assayed for the
level of L-¢colin and were shown to contain 0^2.25 mg/ml L-
¢colin, i.e. much lower than in adult human plasma. The
serum level of collectin MBL increases sharply after birth
and it has been demonstrated to play an important role in
the ¢rst line of immune defence in young children [19,20]. The
increase of the plasma L-¢colin level after birth may play
similar roles.
4. Discussion
L-Ficolin was previously reported to bind to GlcNAc and
similar sugar structures expressed on bacterial surfaces [11,21].
Binding of L-¢colin to S. typhimurium has been reported to
enhance the phagocytosis of the bacteria by polymorphonu-
clear leucocytes [11]. The sugar-binding site in L-¢colin was
not de¢ned in these studies which, however, is important to
the understanding of functional mechanism(s) of L-¢colin.
Like C1q and the collectins, ¢colins also have clear domain
organisations and the di¡erent domains can be isolated by
collagenase or pepsin digestion [14,22,23]. In this study, L-
¢colin was similarly digested with collagenase and a 32 kDa
fragment corresponding to the FBG domain was shown to
retain the GlcNAc-binding activity of L-¢colin. This implies
that, like the collectins, L-¢colin probably binds to sugar res-
idues on microorganisms via the FBG domains and subse-
quently interacts with e¡ector mechanisms, e.g. receptor(s)
on phagocytes, to bring about the killing of the bound micro-
organisms [1,11].
Previous studies showed that L-¢colin bound to GlcNAc
but not a range of other sugars including mannose, glucose,
galactose, lactose and cellobiose [11]. In our previous study, it
was shown that L-¢colin bound CNBr-activated and Tris-re-
acted Sepharose with its GlcNAc-binding site [14]. In the
present study, it was found that L-¢colin could not bind to
glucosamine or galactosamine unless these sugars were N-ace-
tylated. The N-acetylation of the two amino sugars generates
an acetamide structure in each molecule (Fig. 2). Glutathione,
a molecule containing two similar amide groups and otherwise
distinct from GlcNAc and GalNAc, was also shown to bind
L-¢colin implying that the amide groups are probably essential
for L-¢colin binding. This hypothesis was further strengthened
by the fact that CNBr-activated and Tris-derivatised Sephar-
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Fig. 4. Assay of human L-¢colin in the plasma of healthy adults
and that derived from cord blood. Microtitre plates were coated
with rabbit anti-human L-¢colin IgG. Plasma samples were diluted
in TBS-TEDTA-BSA and then incubated in the plates. After wash-
ing, bound L-¢colin was detected with biotinylated anti-¢colin IgG
and streptavidin-alkaline phosphatase. Solid bars represent plasma
samples from healthy adult and hatched bars cord blood plasma
samples.
Fig. 3. Identi¢cation of GlcNAc binding site on L-¢colin. L-Ficolin
was incubated at 37‡C for 24 h in the absence (lane a) or presence
(lane b) of collagenase. Collagenase alone (lane c) was similarly in-
cubated. Collagenase-digested L-¢colin was applied onto a GlcNAc-
Sepharose column (2 ml). After washing, the column was eluted
with 100 mM GlcNAc and the 2nd and 3rd fractions (lanes d and
e) were examined by SDS-PAGE. The samples were examined by
SDS-PAGE under reducing conditions on a 10% (w/v) gel and the
gel was silver-stained.
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ose also generates a structure similar to acetamide. However,
in addition to the amide group or amide-like group, another
structure is clearly required in the L-¢colin FBG ligand(s)
since the amide groups are found in all proteins and many
other molecules, e.g. BSA, which apparently do not bind to L-
¢colin (data not shown).
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